There’s good news for people with severe treatment-resistant depression: esketamine is a groundbreaking therapy that can provide relief from major depression within hours. “For the first time in 60 years, we have a new antidepressant therapy that isn’t just a spinoff of existing drugs,” says Adam Kaplin, M.D., Ph.D., a psychiatrist with Johns Hopkins Medicine. “For some people, esketamine therapy is revolutionary, giving them the chance to experience life without depression for the first time in decades.”
Victory Clinic is a certified outpatient SPRAVATO® treatment center. SPRAVATO® is a prescription nasal spray, FDA-approved to treat adults with treatment-resistant depression (TRD).